BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10856736)

  • 1. Clinical trials update: OPTIME-CHF, PRAISE-2, ALL-HAT.
    Thackray S; Witte K; Clark AL; Cleland JG
    Eur J Heart Fail; 2000 Jun; 2(2):209-12. PubMed ID: 10856736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure.
    Cuffe MS; Califf RM; Adams KF; Bourge RC; Colucci W; Massie B; O'Connor CM; Pina I; Quigg R; Silver M; Robinson LA; Leimberger JD; Gheorghiade M
    Am Heart J; 2000 Jan; 139(1 Pt 1):15-22. PubMed ID: 10618557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial differences in the characteristics of patients admitted for acute decompensated heart failure and their relation to outcomes: results from the OPTIME-CHF trial.
    Echols MR; Felker GM; Thomas KL; Pieper KS; Garg J; Cuffe MS; Gheorghiade M; Califf RM; O'Connor CM
    J Card Fail; 2006 Dec; 12(9):684-8. PubMed ID: 17174228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
    Klein L; Massie BM; Leimberger JD; O'Connor CM; Piña IL; Adams KF; Califf RM; Gheorghiade M;
    Circ Heart Fail; 2008 May; 1(1):25-33. PubMed ID: 19808267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.
    Cuffe MS; Califf RM; Adams KF; Benza R; Bourge R; Colucci WS; Massie BM; O'Connor CM; Pina I; Quigg R; Silver MA; Gheorghiade M;
    JAMA; 2002 Mar; 287(12):1541-7. PubMed ID: 11911756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study.
    Klein L; O'Connor CM; Leimberger JD; Gattis-Stough W; Piña IL; Felker GM; Adams KF; Califf RM; Gheorghiade M;
    Circulation; 2005 May; 111(19):2454-60. PubMed ID: 15867182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study.
    Felker GM; Benza RL; Chandler AB; Leimberger JD; Cuffe MS; Califf RM; Gheorghiade M; O'Connor CM;
    J Am Coll Cardiol; 2003 Mar; 41(6):997-1003. PubMed ID: 12651048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failure.
    Gattis WA; O'Connor CM; Leimberger JD; Felker GM; Adams KF; Gheorghiade M
    Am J Cardiol; 2003 Jan; 91(2):169-74. PubMed ID: 12521629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol titration in patients with congestive heart failure receiving inotropic therapy.
    Kumar A; Choudhary G; Antonio C; Just V; Jain A; Heaney L; Papp MA
    Am Heart J; 2001 Sep; 142(3):512-5. PubMed ID: 11526366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of combination therapy with a beta-blocker and milrinone in patients with advanced heart failure.
    Jennings DL; Thompson ML
    Ann Pharmacother; 2009 Nov; 43(11):1872-6. PubMed ID: 19789358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
    Earl GL; Verbos-Kazanas MA; Fitzpatrick JM; Narula J
    Pharmacotherapy; 2007 May; 27(5):697-706. PubMed ID: 17461705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of a β1-Blocker to Milrinone Treatment Improves Cardiac Function in Patients with Acute Heart Failure and Rapid Atrial Fibrillation.
    Kobayashi S; Myoren T; Kajii T; Kohno M; Nanno T; Ishiguchi H; Nishimura S; Fukuda M; Hino A; Fujimura T; Ono M; Uchinoumi H; Tateishi H; Mochizuki M; Oda T; Okuda S; Yoshiga Y; Kawano R; Yano M
    Cardiology; 2019; 142(4):195-202. PubMed ID: 31137022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.
    Packer M; Carver JR; Rodeheffer RJ; Ivanhoe RJ; DiBianco R; Zeldis SM; Hendrix GH; Bommer WJ; Elkayam U; Kukin ML
    N Engl J Med; 1991 Nov; 325(21):1468-75. PubMed ID: 1944425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effective milrinone therapy to a Duchenne muscular dystrophy patient with advanced congestive heart failure].
    Matsumura T; Saito T; Miyai I; Nozaki S; Kang J
    Rinsho Shinkeigaku; 1999 Jun; 39(6):643-8. PubMed ID: 10502990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update of ELITE-II, BEST, CHAMP, and IMPRESS clinical trials in heart failure.
    Witte K; Thackray S; Banerjee T; Clark AL; Cleland JG
    Eur J Heart Fail; 2000 Mar; 2(1):107-12. PubMed ID: 10742710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OPTIME in CHF trial: rethinking the use of inotropes in the management of worsening chronic heart failure resulting in hospitalization.
    Gheorghiade M; Gattis WA; Klein L
    Eur J Heart Fail; 2003 Jan; 5(1):9-12. PubMed ID: 12559209
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis.
    Einhorn PT; Davis BR; Massie BM; Cushman WC; Piller LB; Simpson LM; Levy D; Nwachuku CE; Black HR;
    Am Heart J; 2007 Jan; 153(1):42-53. PubMed ID: 17174636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.